Both in Pharmaceuticals
Jade Biosciences vs Alto Neuroscience
Over the past year JBIO returned +53.9% and ANRO returned +86.5%; their daily moves had a correlation of 0.40.
JBIO +53.9% ANRO +86.5%Growth of $1, one year, split-adjusted
| Metric | JBIO | ANRO |
|---|---|---|
| Price | $14.57 | $22.70 |
| Market cap | $926.6M | $890.8M |
| Today | +4.59% | +2.30% |
| 1 month | +3.6% | −5.5% |
| 6 months | −42.3% | −10.8% |
| Year to date | −5.6% | +27.5% |
| 1 year | +48.7% | +60.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $461.2M | $225.1M |
| Dividend yield | — | — |
| Volatility (60d) | 52.5% | 56.3% |
| Short % of float | 20.7% | 20.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).